The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus

MLA

Carlos Puig-Jové, et al. “The Novel Inflammatory Biomarker GlycA and Triglyceride-Rich Lipoproteins Are Associated with the Presence of Subclinical Myocardial Dysfunction in Subjects with Type 1 Diabetes Mellitus.” Cardiovascular Diabetology, vol. 21, no. 1, Nov. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12933-022-01652-z.

APA

Carlos Puig-Jové, Josep Julve, Esmeralda Castelblanco, M Teresa Julián, Núria Amigó, Henrik U Andersen, Tarunveer S Ahluwalia, Peter Rossing, Dídac Mauricio, Magnus T Jensen, & Núria Alonso. (2022). The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology, 21(1), 1–11. https://doi.org/10.1186/s12933-022-01652-z

Chicago

Carlos Puig-Jové, Josep Julve, Esmeralda Castelblanco, M Teresa Julián, Núria Amigó, Henrik U Andersen, Tarunveer S Ahluwalia, et al. 2022. “The Novel Inflammatory Biomarker GlycA and Triglyceride-Rich Lipoproteins Are Associated with the Presence of Subclinical Myocardial Dysfunction in Subjects with Type 1 Diabetes Mellitus.” Cardiovascular Diabetology 21 (1): 1–11. doi:10.1186/s12933-022-01652-z.